Political tensions shape global markets

Published 07-MAR-2017 09:25 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

As Wall Street opened on Monday, the focus was on the potential for an escalation in political tensions between North Korea and the US, as well as other nations in the firing line, as the former launched four ballistic missiles into waters off its East Coast, three of which landed inside Japan’s Exclusive Economic Zone.

However, with little detail yet to be released regarding North Korea’s actions and a lack of economic data there was little movement in markets.

The Dow and the NASDAQ came off 0.2% and 0.3% respectively as financials lost momentum following a strong run. The Dow closed at 20,954 points and the NASDAQ 5849 points

Major European markets were all in negative territory with the FTSE 100 falling 0.3% to close at 7350 points.

Financials were the culprits in sending some European markets lower with the most notable being Deutsche Bank AG plunging nearly 8% after announcing that it intended to conduct an €8 billion share sale to make its capital position more robust.

This contributed largely to a 0.6% slide in the DAX which finished at 11,958 points, while the Paris CAC 40 closed at 4972 points, representing a decline of 0.5%.

There was little movement on the commodities front as gold finished towards the bottom of a range which saw it trade between US$1225 per ounce and US$1237 per ounce.

After hitting a high of US$53.56 per barrel in early trading the oil price gave up most of those gains, and as US markets drew to a close it was down 0.2%.

Iron ore came off slightly to slip below the US$90.00 per tonne mark.

All base metals apart from nickel trended lower with copper declining circa 1% to US$2.65 per pound.

Zinc was down nearly 1% while lead only experienced a nominal decline to finish at US$1.02 per pound.

Nickel continued its rally, pushing up above US$5.00 per pound for the first time in a fortnight, a point that marked the end of a sharp and sustained rally of approximately 20% in January/February.

Another break above circa US$5.02 per pound could instil confidence in the prospect of further upside.

The latest run has coincided with a fall in 30 day LME nickel warehouse stocks from approximately 384,000 tonnes to 377,500 tonnes.

After strengthening early in the session, the Australian dollar tapered off to finish broadly in line with the previous day’s close of US$0.758.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X